- Home
- PCVX vs DOCN Comparison
PCVX vs DOCN Comparison
Compare PCVX & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | DOCN |
|---|---|---|
| Founded | 2013 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 8.5B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PCVX | DOCN |
|---|---|---|
| Price | $62.79 | $73.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 14 |
| Target Price | ★ $88.25 | $73.54 |
| AVG Volume (30 Days) | 1.2M | ★ 5.2M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 183.15 |
| EPS | N/A | ★ 2.52 |
| Revenue | N/A | ★ $901,427,000.00 |
| Revenue This Year | N/A | $23.80 |
| Revenue Next Year | N/A | $30.02 |
| P/E Ratio | ★ N/A | $31.74 |
| Revenue Growth | N/A | ★ 15.48 |
| 52 Week Low | $28.09 | $25.56 |
| 52 Week High | $65.00 | $94.66 |
Technical Indicators
Market Signals| Indicator | PCVX | DOCN |
|---|---|---|
| Relative Strength Index (RSI) | 65.54 | 45.10 |
| Support Level | $42.30 | $41.02 |
| Resistance Level | $65.00 | $88.84 |
| Average True Range (ATR) | 2.28 | 7.31 |
| MACD | 0.62 | -2.02 |
| Stochastic Oscillator | 95.44 | 5.76 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About DOCN DigitalOcean Holdings Inc.
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.